HIV/AIDS-Related Cardiology
Metabolic changes occurring with HAART increase heart disease risk
Published in AIDS Weekly, April 11th, 2005
"Highly active antiretroviral therapy (HAART) improves the survival of patients with HIV infection; however, several observational studies have described associations between HIV infection, HAART, and cardiovascular disease. Important limitations of these studies included a low incidence of cardiovascular events, short duration of HAART exposure, and retrospective design.
"Nevertheless, the weight of evidence front observational and surrogate end point studies suggests that the dyslipidemia and other metabolic changes that are common in patients with HIV infection and those...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2005-04-11)
More Articles from AIDS Weekly
- HIV/AIDS Drug Development
Tuftsin-AZT inhibits HIV RT and augments host immunogenic cell function - HIV/AIDS Epidemiology
Low CCR5Delta32 frequency related to higher susceptibility to HIV-1 infection - HIV/AIDS Lipodystrophy
Metabolic and body composition changes vary according to HAART choice - HIV/AIDS Pathogenesis
HIV-1 Vpr inhibits maturation and activation of macrophages and dendritic cells - Arrhythmia
HIV protease inhibitors may predispose patients to cardiac arrhythmias - Avian Influenza
Animal health company launches new Avian Influenza vaccine - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
